Thymosin alfa 1 (TA-1) bụ 28-amino acid peptide nke na-eme n'okike emebere n'ime thymus. Na-eje ozi dị ka immunomodulator endogenous, ọ na-abawanye Mgbochi sel nke T cell nzaghachi; usoro ndị a kapịrị ọnụ gụnyere ọdịiche na maturation nke cell T mkpụrụ ndụ progenitor, ebighị nke mkpụrụ ndụ dendritic na mkpụrụ ndụ egbu egbu eke, tinyere ụdị dị iche iche nke mbufụt nke cytokine.
Ebe ọ bụ na nchoputa ya, ewepụtala nnabata zuru oke nke Thymosin alpha 1's akụrụngwa na-eme ka mgbochi ọrịa.
Usoro
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn
Nọmba CAS
62304-98-7
Usoro ihe omimi
C129H215N33O55
Ibu molekụla
3108.28
Nnyocha nke Thymosin Alpha-1
1.Usoro na arụ ọrụ immunomodulatory
Dị ka pleiotropic immunomodulatory molekul, Ọrụ izizi nke thymosin alpha-1 bụ mweghachi na nkwalite ọrụ mgbochi – immunodeficiency bụ isi ọnọdụ ọ na-achọ imezi.
Na-eme dị ka agonist maka Toll-dị ka nnata (TLR) 9 na TLR-2 na sel dendritic (ọkachamara sel ndị na-eweta antigen), Thymosin alfa 1 na-akpali ime mgbanwe mmeghachi omume mgbochi; viral, nje bacteria, ọrịa fungal na ọrịa kansa bụ ihe niile nwere ike ime ka azịza ndị a pụta.
A na-agbakwunyekwa ihe mgbochi ihu ọchị. Na-ebuli ọkwa nke otutu cytokines (IL-2, IL-10, IL-12, IFNs ịbụ isi ihe atụ) bụ mmetụta ọzọ edekọtara nke ọma.
Na-akpali akpali mmepụta mgbochi-dabere na T cell bụ ihe a na-enyekarị maka ihe ndị na-enyere ya aka.
Ihe omume ndu ụdịdị dị iche iche, antitumor n'etiti ha, a na-enyocha ya ugbu a.
2.Ngwa Clinical na ike ọgwụgwọ
(1)Ọgwụgwọ nke Ọrịa Viral
Ọnwụnwa ụlọọgwụ enyochala nchekwa na ịdị irè nke thymosin alpha 1 na-adịghị ala ala ịba ọcha n'anya B(HBV) ndị ọrịa. Nkwalite mkpochapụ nje na iweghachi ọrụ imeju na-esote site na nzaghachi T-cell kpọmkwem megide HBV.
Ngwakọta ọgwụgwọ na pegylated interferon dị irè na ịba ọcha n'anya C; thymosin n'onwe ya ma ọ bụ yana njikọ interferon, ka bụ nhọrọ ọgwụgwọ kwesịrị ekwesị.
Ọgwụ nje na-eme ihe ozugbo ewepụrụ thymosin na ọgwụgwọ nke mbụ, mana mmetụta na-akwalite mgbochi nke thymosin alpha 1 nọgide na-adị mkpa na ụlọ ọgwụ.
(2)Na-egbochi uto Tumor
Ọtụtụ ọmụmụ egosila ngwa na-ekwe nkwa maka thymosin alpha-1 na ndị ọrịa nwere metastatic melanoma, isi na olu cancer, ọrịa cancer akpa ume, ọrịa ara ara, na hepatocellular carcinoma.
Ejiri ya dị ka ọgwụgwọ mgbakwunye, ọ na-ekwu maka mgbochi immunosuppressed chemotherapy, isi immunodeficiency, na ụdị dị iche iche nke immunosuppressive steeti.
Ijikọta thymosin alpha-1 na ma ọ bụ chemotherapy ma ọ bụ redio egosila ọ̀tụ̀tụ̀ dị ndụ ka mma; cancer akpa ume na-abụghị obere cell (Ọnụ ọgụgụ ka ukwuu nke ọrịa cancer akpa ume niile) ịbụ ezigbo ihe atụ, adịghị mma chemosensitivity bụ otu n'ime isi ihe ịma aka na ọrịa a.
(3)Ọgwụgwọ nke Sepsis
A na-arụ ọrụ Thymosin alpha-1 na ọgwụgwọ nke usoro immunosuppressive nke sepsis.
Iweghachi ma ọnụọgụ na ọrụ nke lymphocytes – Mkpụrụ ndụ T bụ isi ihe – a na-atụ anya na ọ ga-atụgharị ọnọdụ ahụ mkpọnwụ ahụ.
Na-ehichapụ ọrịa mbụ, ibelata ọrịa nke abụọ na-esote, na imeziwanye prognosis bụ uru pụtara ìhè nke ọgwụgwọ a.
Ọmụmụ ụlọ ọgwụ akwadola ngwa ndị na-ekwe nkwa, naanị ya ma ọ bụ yana ọgwụ ndị ọzọ.
(4)Dị ka ihe enyemaka ịgba ọgwụ mgbochi ọrịa
Adjuvant ọgwụ mgbochi bụ ebe thymosin alpha-1 na-egosi ụfọdụ mmetụta ya na-agbanwe agbanwe yana bara uru.
Nzaghachi mgbochi sel siri ike dị mkpa maka mgbochi ma ọ bụ ọgwụgwọ ọtụtụ ọrịa; ụkwara nta, AIDS, na ọgwụgwọ ọrịa kansa ọgwụ mgbochi ịbụ ihe atụ ama ama.
Ọgwụ mgbochi influenza (karịsịa maka ndị agadi) a na-amụ ugbu a site na iji adjuvant a, na nti ụlọ ọgwụ pụta.
(5)Ngwakọta ọgwụgwọ maka HIV na ọgwụ ndị ọzọ
Na-ejikọta thymosin alpha-1 na interferon-a1 na zidovudine enhances dịghịzi ọrụ.
CD4+ ọnụ ọgụgụ na-abawanye, ibu nje na-ebelata ma na-emeziwanye ọnọdụ ụlọ ọgwụ nke ndị ọrịa HIV.
Nlekọta ogologo oge nke thymosin alpha-1 dị elu na-anọchite anya ụzọ dị mkpa immunomodulatory.
Thymosin alpha-1 na-anọgide na-abụ n'ezie pleiotropic immunomodulator nwere nnukwu ọgwụgwọ ike..
COA
HPLC
MS





